Cargando…
Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
IMPORTANCE: Antiobesity pharmacotherapy is recommended for adolescents ages 12 years and older with obesity. Several medications have been approved by the US Food and Drug Administration for adolescent use, but the most cost-effective medication remains unclear. OBJECTIVE: To estimate the cost-effec...
Autores principales: | Lim, Francesca, Bellows, Brandon K., Tan, Sarah Xinhui, Aziz, Zainab, Woo Baidal, Jennifer A., Kelly, Aaron S., Hur, Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472196/ https://www.ncbi.nlm.nih.gov/pubmed/37651143 http://dx.doi.org/10.1001/jamanetworkopen.2023.29178 |
Ejemplares similares
-
Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes
por: Lauren, Brianna N., et al.
Publicado: (2022) -
The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
por: Lee, Minyi, et al.
Publicado: (2019) -
Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened
por: Aziz, Zainab, et al.
Publicado: (2023) -
Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome
por: Wright, Jason D., et al.
Publicado: (2021) -
Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity
por: Srivastava, Gitanjali, et al.
Publicado: (2019)